Medicox KRX:054180KOSDAQ
메디콕스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked13since Sep 11
In Q2 2026, Medicox reported revenue of ₩6.4bn, down 16.0% year on year, and an operating loss of ₩1.1bn. Medicox (메디콕스) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 18 with 1 article.
Filing signals 4 quarters of losses Litigation Delisting / halt risk Screener
Medicox quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩6.4bn | -16.0% | −₩1.1bn margin −17.3% | −₩1.1bn |
| Q1 2026 | ₩6.3bn | -7.2% | −₩1.0bn margin −16.3% | −₩1.6bn |
| Q4 2025 derived | ₩7.0bn | -14.6% | −₩1.3bn margin −19.3% | −₩3.4bn |
| Q3 2025 | ₩6.7bn | -12.1% | −₩923m margin −13.8% | −₩1.9bn |
| Q2 2025 | ₩7.7bn | +4.2% | −₩1.5bn margin −18.9% | −₩3.7bn |
| Q1 2025 | ₩6.8bn | -8.7% | −₩2.0bn margin −29.7% | −₩2.9bn |
| Q4 2024 derived | ₩8.2bn | +9.1% | −₩2.1bn margin −26.2% | −₩7.3bn |
| Q3 2024 | ₩7.6bn | +15.3% | −₩2.2bn margin −29.5% | −₩3.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Medicox top stories 2 weeks, by number of outlets
- 1
Latest Medicox news Korean headlines
-
메디콕스, 경남 고성 공장 57.5억원에 양도
2 more on this story · 2 outlets
- 메디콕스, 경남 고성 공장 57.5억원에 양도이데일리증권 · Oct 15 15:17
- 메디콕스, 경남 고성 공장 57.5억원에 양도이데일리 · Oct 15 15:20
-
메디콕스, 상장폐지 결정 효력정지 가처분 신청
2 more on this story · 1 outlets
- 메디콕스, 상장폐지 결정 효력정지 가처분 신청이데일리 · Oct 1 15:17
- 메디콕스, 상장폐지 결정 효력정지 가처분 신청이데일리 · Oct 1 15:19